Last edition
News about
Zylox-Tonbridge to Acquire Germany's Optimed in a Move to Expand Global Vascular Devices Footprint
Multi-step acquisition of Optimed strengthens Zylox-Tonbridge’s European footprint, R&D capabilities and global commercialisation of minimally invasive vascular solutions.
Boston Scientific will acquire Penumbra in a USD 14.5 billion cash and stock deal to expand its vascular and neurovascular portfolio, strengthening its position in thrombectomy, stroke, and cardiovascular disease treatment markets.
Serum Institute to Produce 100,000 Doses of Oxford Rift Valley Fever Vaccine
Serum Institute of India will produce up to 100,000 doses of an investigational Rift Valley fever vaccine developed by the University of Oxford, as the viral disease continues to affect parts of West Africa. The doses may be used for testing and future outbreak response, under an agreement supported by CEPI.
ISCR Urges Union Budget 2026 to Focus on Boosting India's Clinical Research Ecosystem
ISCR seeks higher funding, AI-led innovation and regulatory reforms in Union Budget 2026 to boost global competitiveness and accelerate patient access to therapies.
Organon Wins FDA Approval to Extend Duration of Use for NEXPLANON
Organon has received US Food and Drug Administration (FDA) approval for a supplemental New Drug Application extending the duration of use of NEXPLANON, its etonogestrel radiopaque contraceptive implant, to up to five years, expanding the product’s earlier three-year indication and offering longer-lasting contraceptive protection.
Miach Orthopaedics’ BEAR Implant becomes the first sports medicine device to carry an FDA-cleared claim for lowering long-term osteoarthritis risk compared with traditional ACL reconstruction.
Sun Pharma Launches UNLOXCYT for Advanced Cutaneous Squamous Cell Carcinoma
Sun Pharma has announced the US availability of UNLOXCYT for adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not eligible for curative surgery or radiation. The updated label includes long-term data supporting durable efficacy and a favourable tolerability profile.
The silicon photonics based imaging platform, Leadoptik’s LIA system, delivers real-time, high-resolution tissue insight at the point of care, addressing a critical gap in lung cancer diagnosis.
GCCL and OPIS Forge Strategic Alliance to Expand Global Clinical Trial Services
GCCL, a South Korea-based leader in clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have entered into a Memorandum of Understanding (MoU) to deepen collaboration and enhance their footprint in the global clinical trial market.
Viz.ai Launches Real-Time Clinical Intelligence Service for Salesforce Agentforce Life Sciences
The new service integrates Viz.ai’s real-time clinical data from nearly 2,000 hospitals to power intelligent, closed-loop agentic workflows for life sciences organisations.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy